Gene expression profiles of hepatoma cell line BEL-7402

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1496-1501

  Liu, Lian Xin ^a,b   Jiang, Hong Chi ^a   Liu, Zhi Hua ^b   Zhu, An Long ^a   Zhou, Jing ^b   Zhang, Wei Hui ^a   Wang, Xiu Qin ^b   Wu, Min ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Gene expression profiles; Hepatocellular carcinoma; Hepatoma; Microarray; Northern blot; Reverse transcription polymerase chain reaction (RT PCR)

Indexed keywords

BETA8 INTEGRIN; CASPASE 3; COMPLEMENTARY DNA; CYCLINE; INTEGRIN; PHOSPHORUS 32; PROTEIN BAK; PROTEIN KINASE B; RNA; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GROWTH REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; LIVER TRANSPLANTATION; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0141651591     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schafer DF, Sorrell MF: Hepatocellular carcinoma. Lancet 1999; 353:1253-1257.
2. Naka T, Toyota N, Kaneko T, Kaibara N: Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 1998; 18:555-564.
3. Montesano R, Hainaut P, Wild CP: Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 1997; 89:1844-1851.
4. Collier JD, Guo K, Gullick WJ, Bassendine MF, Burt AD: Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver 1993; 13:151-155.
5. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467-470.
6. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyses gene expression patterns in human cancer. Nat Genet 1996; 14:457-460.
7. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J: Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999; 229:101-108.
8. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24:227-235.
9. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998; 58:5009-5013.
10. Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G, Zhao L, Qiu Z, Zhou C, Wu M: Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001; 91:288-294.
11. Kallioniemi OP: Biochip technologies in cancer research. Ann Med 2001; 33:142-147.
12. Khan J, Saal LH, Bittner ML, Chen Y, Trent JM, Meltzer PS: Expression profiling in cancer using cDNA microarrays. Electrophoresis 1999; 20:223-229.
13. Hu YC, Lam KY, Law S, Wong J, Srivastava G: Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001; 7:2213-2221.
14. Selaru FM, Zou T, Xu Y, Shustova V, Yin J, Mori Y, Sato F, Wang S, Olaru A, Shibata D, Greenwald BD, Krasna MJ, Abraham JM, Meltzer SJ: Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 2002; 21:475-478.
15. Unger MA, Rishi M, Clemmer VB, Hartman JL, Keiper EA, Greshock JD, Chodosh LA, Liebman MN, Weber BL: Characterization of adjacent breast tumors using oligonucleotide microarrays. Breast Cancer Res 2001; 3:336-341.
16. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR: E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 1998; 12:2120-2130.
17. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K: The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 1993; 13:7813-7825.
18. Moberg K, Starz MA, Lees JA: E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996; 16:1436-1449.
19. Zhang Y, Chellappan SP: Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 1995; 10:2085-2093.
20. Zhang Y, Venkatraj VS, Fischer SG, Warburton D, Chellappan SP: Genomic cloning and chromosomal assignment of the E2F dimerization partner TFDP gene family. Genomics 1997; 39:95-98.
21. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995; 374:733-736.
22. Cosulich SC, Worrall V, Hedge PJ, Green S, Clarke PR: Regulation of apoptosis by BH3 domains in a cell-free system. Curr Biol 1997; 7:913-920.
23. Kumar S: The apoptotic cysteine protease CPP32. Int J Biochem Cell Biol 1997; 29:393-396.
24. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J Biol Chem 1996; 271:27099-27106.
25. Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998; 10:262-267.
26. Alessi DR, Cohen P: Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 1998; 8:55-62.
27. Jackson SP: DNA-dependent protein kinase. Int J Biochem Cell Biol 1997; 29:935-938.
28. Lee SE, Mitchell RA, Cheng A, Hendrickson EA: Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol 1997; 17:1425-1433.
29. Denda S, Reichardt LF, Muller U: Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998; 9:1425-1435.
30. Denda S, Muller U, Crossin KL, Erickson HP, Reichardt LF: Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. Biochemistry 1998; 37:5464-5474.
31. Fogerty FJ, Akiyama SK, Yamada KM, Mosher DF: Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies. J Cell Biol 1990; 111:699-708.